Nicolò Matteo Luca Battisti, European Cancer Summit 2020 – Inequalities in Cancer Care
Discrimination in cancer care is a major ongoing issue across Europe and has been exacerbated during the COVID-19 pandemic. Nicolò Matteo Luca Battisti discusses how the resolution from this year’s European Cancer Summit will help overcome these disparities.
- Could you give us an overview of the issue of discrimination in cancer care?
- What are the major disparities in cancer care across Europe?
- How is the COVID-19 pandemic affecting these disparities?
- How can we achieve policy change to combat disparities and discrimination?
- What was the resolution of this year’s European Cancer Summit on this issue?
Speaker Disclosures: Nicolò Matteo Luca Battisti has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of the European Cancer Summit 2020.
Share this Video
Related Videos In Supportive Cancer Care
Professor D’Ugo: Don’t Miss Out on Registering for the ESSO 40!
Professor Domenico D’Ugo, President of the European Society of Surgical Oncology (ESSO), shares what we can look forward to at the annual meeting in November!
Domenico D’Ugo, ESSO 40: Hot Topics, What to Expect and Why Should HCPs Register
touchONCOLOGY were delighted to speak with Professor Domenico D’Ugo, President of the European Society of Surgical Oncology (ESSO) one our media partners. He discusses why healthcare professionals should register and attend the ESSO 40 conference in November 2021 in Lisbon and what we can look forward to. Questions 1. What can we expect from ESSO […]
Professor Domenico D’Ugo: Current Initiatives at ESSO and Looking to the Future
Professor Domenico D’Ugo, President of the European Society of Surgical Oncology (ESSO) one our valued media partners at touchONCOLOGY, discusses the latest from the society and his hopes for oncology management post-COVID19 in 2022. Questions 1. Please tell us about any initiatives that ESSO are currently working on? (00:15-02:24) 2. What can we expect in […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!